AstraZeneca Plc investors had a clear message for the UK drugmaker on Monday: they don't like the idea of a $400 billion merger with Bristol-Myers Squibb Co. Bloomberg Intelligence's Director of Research, Sam Fazeli joins to discuss.
The new trend among the rich is "tax alpha," or lowering one's tax bill while generating more profit along the way. It can be traced to a quadrupling of the S&P 500 over the past decade.
A volatile month for US equities ended on a higher note Friday, with the S&P 500 Index clocking a 1.1% weekly advance. Much of the comeback can be linked to gains in technology stocks on Thursday and Friday, particularly Microsoft. and Amazon. Sarah Hunt, Chief Market Strategist at Alpine Saxon Woods, discusses recent tech earnings and their market impact as traders look ahead to jobs data this week.
Standard Chartered's Suki Cooper joins Bloomberg Open Interest to explain why gold could resume its climb toward 5,000. She says central-bank demand, geopolitical uncertainty, and portfolio diversification remain powerful supports, while recent price resilience suggests gold has established a durable floor despite higher yields and weak ETF positioning.
Standard Chartered's Suki Cooper joins Bloomberg Open Interest to explain why gold could resume its climb toward 5,000. She says central-bank demand, geopolitical uncertainty, and portfolio diversification remain powerful supports, while recent price resilience suggests gold has established a durable floor despite higher yields and weak ETF positioning.
Pimco President Christian Stracke says the financing of digital infrastructure is only in the early innings. Speaking on "Bloomberg Open Interest," Stracke also discusses the risks in the lending market, the private credit "confidence gap" and where he sees financing opportunities in the current environment.
Stagwell CEO Mark Penn joined Bloomberg Open Interest to explain how AI is helping the marketing challenger win major global clients and deliver everything from smarter targeting to faster production. He argues that AI won't replace agencies because managing thousands of enterprise campaigns still demands technology, creativity and human expertise.
The yen rallied sharply on Monday amid speculation that authorities may have intervened to prop up the currency again after coordinated action between the US and Japan last week. Sonja Marten, Chief Economist at DZ Bank, discusses the global market reaction to the US and Japan taking action on the yen.
On this episode of Stock Movers: - Bristol-Myers Squibb (SQB) shares are surging on news AstraZeneca (AZN), whose shares are lower, is exploring an acquisition of Bristol-Myers Squibb. - Tyson (TSN) shares are dropping after the protein producer reported a 3Q sales shortfall, driven by a 16% reduction in beef sales volume, and cut its total company and beef profit forecasts for the full year. - SpaceX (SPCX) shares are moving as investors in the company prepare for its first earnings report as a public company.
AstraZeneca shares plunged Monday on news that the drugmaker was exploring an acquisition of Bristol Meyers Squibb. A deal would create one of the world's biggest drugmakers. Sam Fazeli of Bloomberg Intelligence says a takeover would make no sense.
Two Republican senators are backing a deal with acting Attorney General Todd Blanche to formally rescind an order creating an "anti-weaponization fund," likely paving the way for Blanche's confirmation as the nation's top law enforcement officer. Jeff Mason reports on Bloomberg Television.
US and Japanese officials warned investors they're determined to keep defending the yen after their first joint intervention in 15 years. The yen surged Monday morning. Bloomberg's Cameron Crise talks about what the US and Japan hope to achieve.
